Trump’s F.D.A. Pick Could Undo Decades of Drug Safeguards by KATIE THOMAS

By KATIE THOMAS

A top candidate to head the agency, Jim O’Neill, advocates “progressive” approval, in which drugs proved safe could be sold to consumers even if not yet proved effective.

Published: February 4, 2017 at 07:00PM

from NYT Health http://ift.tt/2jPFAN5
via IFTTT

from WordPress http://ift.tt/2kCD3Wc
via IFTTT